Search by Drug Name or NDC
NDC 11673-0494-32 Allergy Relief 25 mg/1 Details
Allergy Relief 25 mg/1
Allergy Relief is a ORAL TABLET in the HUMAN OTC DRUG category. It is labeled and distributed by TARGET CORPORATION. The primary component is DIPHENHYDRAMINE HYDROCHLORIDE.
MedlinePlus Drug Summary
Diphenhydramine is used to relieve red, irritated, itchy, watery eyes; sneezing; and runny nose caused by hay fever, allergies, or the common cold. Diphenhydramine is also used to relieve cough caused by minor throat or airway irritation. Diphenhydramine is also used to prevent and treat motion sickness, and to treat insomnia (difficulty falling asleep or staying asleep). Diphenhydramine is also used to control abnormal movements in people who have early stage parkinsonian syndrome (a disorder of the nervous system that causes difficulties with movement, muscle control, and balance) or who are experiencing movement problems as a side effect of a medication. Diphenhydramine will relieve the symptoms of these conditions but will not treat the cause of the symptoms or speed recovery. Diphenhydramine should not be used to cause sleepiness in children. Diphenhydramine is in a class of medications called antihistamines. It works by blocking the action of histamine, a substance in the body that causes allergic symptoms.
Related Packages: 11673-0494-32Last Updated: 03/24/2024
MedLinePlus Full Drug Details: Diphenhydramine
Product Information
| NDC | 11673-0494 |
|---|---|
| Product ID | 11673-494_085d79ef-5e52-fac1-e063-6394a90a5f60 |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | Allergy Relief |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Diphenhydramine HCl |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 25 |
| Active Ingredient Units | mg/1 |
| Substance Name | DIPHENHYDRAMINE HYDROCHLORIDE |
| Labeler Name | TARGET CORPORATION |
| Pharmaceutical Class | Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC] |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH DRUG |
| Application Number | M012 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 11673-0494-32 (11673049432)
| NDC Package Code | 11673-494-32 |
|---|---|
| Billing NDC | 11673049432 |
| Package | 300 TABLET in 1 BOTTLE (11673-494-32) |
| Marketing Start Date | 2023-10-20 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |